Amitiza and Device expulsion - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Amitiza?
Amitiza has active ingredients of lubiprostone. It is used in constipation. Currently, eHealthMe is studying from 10,181 Amitiza users.
What is Device Expulsion?
Device expulsion is found to be associated with 784 drugs and 482 conditions by eHealthMe. Currently, we are studying 56,897 people who have Device expulsion.
Do you take Amitiza and have Device expulsion?Check whether Device expulsion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Device expulsion and when was it recovered:
Expand to all the drugs that have ingredients of lubiprostone:
Alternative drugs to, pros and cons of Amitiza:
- Amitiza (10,181 reports)
Browse all side effects of Amitiza:a b c d e f g h i j k l m n o p q r s t u v w x y z
Device expulsion treatments and more:
- Device expulsion (56,897 reports)
All the drugs that are associated with Device expulsion:
All the conditions that are associated with Device expulsion:
How the study uses the data?
The study uses data from the FDA. It is based on lubiprostone (the active ingredients of Amitiza) and Amitiza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Benicar and Testosterone drug interaction - now
- Sulfatrim and Tamoxifen Citrate drug interaction - 3 seconds ago
- Velcade and Respiratory Rate Increased - 5 seconds ago
- Olanzapine and Trismus - 14 seconds ago
- Xanax and Emphysema - 15 seconds ago
- How effective is Lipitor for Parkinson'S Disease? - 18 seconds ago
- Tacrolimus and International Normalised Ratio Increased - 19 seconds ago
- Flonase and Sandimmune drug interaction - 23 seconds ago
- Clopidogrel and Fibromyalgia - 37 seconds ago
- Norvir and Heart Disease - 38 seconds ago